Press release
The APAC HIV Rapid Test Kits Market is Projected to Reach USD 487.70 Million by 2028, with a CAGR of 2.57% - Arizton
Get Detailed Insight @ https://www.focusreports.store/report/asia-pacific-hiv-rapid-test-kits-insights
Online Channels Transforming HIV Test Kit Distribution in APAC
In 2022, the online distribution channel segment captured a 31.23% share of the APAC HIV rapid test kits market. The growing trend towards online shopping has prompted companies to transition from offline to online sales, a shift that is particularly evident in the HIV test kits sector. Consequently, there has been a slowdown in the growth of offline-based HIV self-tests.
In response to this shift, several developed countries have implemented policies to support HIV self-testing and facilitate access to test kits through online channels. Online pharmacies and medical shops have emerged as key players in meeting the demand for HIV self-testing kits. Additionally, regulatory bodies like the Center for Disease Control and Prevention have recommended the availability of FDA-approved HIV rapid test kits through online sales channels in the US and other nations, further encouraging the expansion of online distribution networks for HIV testing solutions.
In APAC, HIV testing is the most vital and integral part of HIV prevention and management. The knowledge about HIV infection is increasing rapidly in the region, which is expected to accelerate the demand for HIV self-testing kits. The APAC HIV rapid test kits market is experiencing healthy growth due to the awareness of HIV status, the rise in the target patient population, and the increase in government support & funding for HIV management. China is the largest HIV rapid test kits market in APAC, followed by India and Indonesia. However, introducing new and innovative HIV rapid test kits products with better process management and advanced technologies is expected to increase the application of lateral flow immunoassay during the forecast period. Hence, the lateral flow immunoassay segment will likely increase its share from 83.38% in 2022 to 83.83% in 2028.
China to Hold the Dominate Share in the APAC HIV Rapid Test Kits Market
The China HIV rapid test kits market is anticipated to surge to $189 million by 2028, driven by factors such as heightened awareness of HIV status among the populace, an expanding target demographic, and advanced healthcare infrastructure. As per the UNAID 2018 report, China had approximately 1.25 million people living with HIV, with 69% aware of their status and around 83% accessing treatments. The adoption of HIV self-testing (HIVST) was notably boosted in 2018, supported by Chinese health authorities and the government, leading to a substantial increase in uptake among adults. In the APAC region, the China market has emerged as a frontrunner in the HIV rapid test kits sector, showcasing greater dominance than other nations. This growth trajectory underscores the evolving landscape of HIV testing and healthcare accessibility in China.
Looking for More Info? Click: https://www.focusreports.store/report/asia-pacific-hiv-rapid-test-kits-insights
Market Opportunities & Trends
•4th Generation HIV Kit Technology to Increase Reliability and Accuracy in Testing
•Development of Upconverting Nanoparticle-based Lateral Flow Immunoassay
•Digital Technology & Tools support HIV Self-testing Proliferation
•Increasing Resources Availability and Fundings for HIV Management
Vendors Included in the Report:
Key Vendors: Abbott Laboratory, Bio-Rad Laboratory, BioMerieux, ChemBio Diagnostics, & OraSure Technologies
Other Prominent Vendors: bioLytical Laboratories, Biosynex, DIALAB, AccuBioTech, Cupid Limited, Nanjing Synthgene Medical Technology, HUMAN Diagnostics World, INTEC, J. Mitra & Co., Meril Life Sciences, MP Biomedicals, Medsource Ozone Biomedicals, Premier Medical, SD Biosensor, Türklab A.S., Trinity Biotech, Atomo Diagnostics, KHB (SHANGHAI KEHUA BIO-ENGINEERING), Wantai BioPharma, and Wondfo
About Focus Reports by Arizton
Welcome to Focus Reports, an esteemed Arizton Advisory & Intelligence subsidiary committed to delivering precise and insightful market research reports across all key geographies. Our unique selling proposition lies in our affordable pricing, accurate data, in-depth research, and presentation-ready reports. With us, expensive market research is outdated. We aim to be strategic, providing valuable data.
Contact Us:
Call: +1-312-235-2040
+1 302 469 0707
Mail: enquiry@arizton.com
Website: https://www.focusreports.store/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The APAC HIV Rapid Test Kits Market is Projected to Reach USD 487.70 Million by 2028, with a CAGR of 2.57% - Arizton here
News-ID: 3485725 • Views: …
More Releases for HIV
HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792
This latest report researches the industry structure, sales, revenue,…
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
